Trial intelligence / Profile preview

Memantine on Brain Atrophy in Alzheimer's Disease

NCT00862940Phase 4Completed

Sponsor
Lundbeck
Start
Sep 2005
Primary completion
Feb 2009
Modality
Small Molecules
01

Overview

A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Lundbeck. Started Sep 2005; status: completed.

02

Drugs

memantine
03

Conditions

Alzheimer's disease (AD)

Beyond the preview

Go deeper on NCT00862940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00862940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call